PROS1, a clinical prognostic biomarker and tumor suppressor, is associated with immune cell infiltration in breast cancer: A bioinformatics analysis combined with experimental verification
- Resource Type
- Article
- Source
- In
Cellular Signalling December 2023 112 - Subject
- Language
- ISSN
- 0898-6568